Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
HealthStream operates a cloud-based healthcare workforce development platform serving approximately 6.5 million healthcare professionals across hospitals, health systems, and pharmaceutical companies. The company provides compliance training, clinical development, credentialing, and scheduling software primarily to US healthcare organizations, generating recurring subscription revenue with high gross margins but modest operating leverage due to content development and customer support costs.
HealthStream generates recurring subscription revenue through multi-year contracts with healthcare organizations that require continuous workforce training for regulatory compliance (Joint Commission, OSHA, CMS requirements). Pricing is typically per-learner or per-facility with annual escalators. The company benefits from high switching costs due to integration with hospital HR systems, extensive content libraries built over 25+ years, and the mission-critical nature of compliance training. Gross margins exceed 65% due to software scalability, but operating margins remain constrained by ongoing content development costs, sales force expenses, and customer success teams required to maintain retention rates above 90%.
Subscriber growth rates and net revenue retention (expansion minus churn) across the installed base of 6+ million healthcare professionals
New logo wins at large health systems (100+ hospital IDNs) which drive multi-year recurring revenue streams
Pricing realization and ability to pass through annual price increases (typically 2-4%) without impacting retention
Product innovation velocity, particularly AI-enabled personalized learning pathways and mobile-first delivery that differentiate from legacy LMS competitors
M&A activity for tuck-in acquisitions that expand content libraries or add adjacent capabilities like scheduling or workforce analytics
Commoditization of learning management systems as enterprise HR platforms (Workday, Oracle, SAP SuccessFactors) add training modules, potentially reducing willingness to pay for specialized healthcare LMS
Regulatory changes reducing mandatory continuing education requirements or shifting to competency-based assessments rather than time-based training hours
Generative AI disruption enabling hospitals to create custom training content in-house at lower cost, eroding HealthStream's content library moat
Shift toward gig economy healthcare staffing models reducing demand for enterprise-wide training platforms as contract workers bring their own credentials
Relias Learning (owned by private equity) aggressively pricing to gain market share in behavioral health and senior living segments
Large EMR vendors (Epic, Cerner/Oracle) bundling basic training capabilities into core hospital information systems, reducing addressable market for standalone solutions
New entrants leveraging modern tech stacks and mobile-first design to win younger healthcare workers who find HealthStream's interface dated
Minimal financial leverage (4% debt-to-equity) and positive free cash flow generation eliminate near-term liquidity concerns
Low ROE (5.8%) and ROA (9.5%) relative to software peers suggest capital allocation challenges or margin structure issues limiting profitability
Deferred revenue balance provides visibility but also represents performance obligation risk if service delivery falters
low - Healthcare workforce compliance training is non-discretionary spending driven by regulatory mandates rather than economic conditions. Hospitals must maintain Joint Commission accreditation and CMS certification regardless of GDP growth. However, severe recessions can pressure hospital operating budgets, potentially delaying expansion purchases or driving price sensitivity. New hospital construction and staffing expansion correlate with healthcare utilization trends, which have modest GDP sensitivity.
Rising interest rates have modest negative impact through two channels: (1) higher discount rates compress valuation multiples for recurring revenue software businesses, particularly affecting growth-stage SaaS companies trading at premium multiples, and (2) hospital capital budgets face pressure from increased debt service costs, potentially slowing technology adoption. However, HealthStream's low debt load (0.04x D/E) insulates it from direct financing cost increases. The company's mature, cash-generative profile reduces rate sensitivity compared to high-growth, unprofitable SaaS peers.
Minimal direct credit exposure. HealthStream's customer base consists primarily of investment-grade hospital systems and pharmaceutical companies with strong balance sheets. Healthcare provider bankruptcies are rare given essential service nature. The company maintains minimal debt and generates positive operating cash flow, eliminating refinancing risk. Credit market tightening could indirectly impact M&A capacity if acquisition financing becomes expensive, but organic growth model does not depend on credit availability.
value - The stock trades at 2.0x Price/Sales and 8.5x EV/EBITDA, below typical SaaS multiples (5-10x revenue for growth companies), attracting value investors seeking profitable, cash-generative software businesses at reasonable valuations. The 40% one-year decline has created potential entry point for investors betting on stabilization and modest margin expansion. Limited growth (4.5% revenue growth) and small market cap ($600M) reduce appeal to growth-at-any-price investors. Dividend-focused investors are not attracted given no indicated dividend policy.
moderate - Small-cap healthcare IT stocks exhibit higher volatility than large-cap healthcare due to lower liquidity and susceptibility to sector rotation. However, recurring revenue model and non-cyclical end market provide downside support. The 40% annual decline suggests elevated recent volatility, likely driven by growth deceleration concerns or competitive pressures. Beta likely ranges 1.0-1.3x relative to broader market.
